Alcon   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Fort Worth TX United States (1945)
Status: Acquired by Nestle (1977)

Organization Overview

First Clinical Trial
1999
NCT00346957
First Marketed Drug
1959
chymotrypsin (zolyse)
First NDA Approval
1959
chymotrypsin (zolyse)
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ALCON | Alcon, a Novartis Division | Alcon, A Novartis Division | Alcon (China) Ophthalmic Product Co., Ltd. | Alcon Global Medical Affairs, Europe | Alcon Japan, Ltd. | ALCON LABS | ALCON LABS INC | ALCON PHARMA | ALCON PHARMS LTD | ALCON RES | Alcon Research | Alcon Research, LLC | Matthew Caldwell